BioTime, Inc.
Blood volume expander developer announces new patent in China
Published in Medical Device Law Weekly, August 14th, 2005
BioTime's second Chinese Patent No. ZL 00806029.0 issued on May 11, 2005, with broad claims covering the use of Hextend and PentaLyte in the treatment of hypovolemia. This new Chinese patent will be in force until January 24, 2020 and therefore provides important complementary proprietary rights to BioTime's Chinese Patent No. ZL 94192801.2 that issued on March 12, 2003, with claims to the composition of Hextend and PentaLyte.
Hextend is BioTime's proprietary physiologically balanced blood plasma volume expander...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Biophan Technologies, Inc.
Medical device firm's intellectual property portfolio expands to 140 - Caliper Life Sciences, Inc.
LabChip technology licensed for diagnostic applications - Cambridge Heart
U.S. CMS opens National Coverage Determination for Microvolt T-Wave Alternans - Cholestech
Seniors get more cholesterol screenings with new Medicare reimbursement levels - Dermisonics, Inc.
U.S. Patent issued for ultrasonics-assisted transdermal drug delivery technology - Endocare, Inc.
Tumor ablation company announces strategy to achieve national listing - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
